Electroconvulsive shock enhances striatal dopamine D1 and D 3 receptor binding and improves motor performance in 6-OHDA-lesioned rats

Journal of Psychiatry and Neuroscience

Volumn 32, Issue 3, 2007, Pages 193-202

  Strome, Elissa M ^a   Zis, Athanasios P ^a   Doudet, Doris J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dopamine receptors; Electroconvulsive therapy; Motor skills; Parkinson disease

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; ELECTRIC SHOCK; FOREBRAIN; LIMB MOVEMENT; MALE; MOOD DISORDER; MOTOR PERFORMANCE; NONHUMAN; PARKINSONISM; PROTEIN BINDING; RAT; SUBSTANTIA NIGRA; UPREGULATION;

EID: 34250184963     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-55.
2. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(Suppl 11):S11-6.
3. Leentjens AF. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 2004;17:120-6.
4. Kho KH, van Vreeswijk MF, Simpson S, et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003;19:139-47.
5. Pagnin D, de Quriroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004;20:13-20.
6. Kennedy R, Mittal D, O'Jile J. Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci 2003;15:407-21.
7. Fall PA, Ekman R, Granerus AK, et al. ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect 1995;10:129-40.
8. Zervas IM, Fink M. ECT for refractory Parkinson's disease. Convuls Ther 1991;7:222-3.
9. Andersen K, Balldin J, Gottfries CG, et al. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand 1987;76:191-9.
10. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 1984;83:235-42.
11. 2 receptor number in frontal cortex. Br J Pharmacol 1983;80:377-85.
12. Yoshida K, Higuchi H, Kamata M, et al. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:435-44.
13. 2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine- mediated behaviour following repeated electroconvulsive shock administration to rats. Br J Pharmacol 1983;80:173-7.
14. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-47.
15. Angelucci F, Aloe L, Jimenez-Vasquez P, et al. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 2002;18:138-43.
16. Malberg JE, Eisch AJ, Nestler EJ, et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-10.
17. Vaidya VA, Siuciak JA, Du F, et al. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999;89:157-66.
18. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
19. Jackson DM, Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994;64:291-369.
20. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93-6.
21. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-32.
22. Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol 1988;102:318-24.
23. Feeney DM, Bailey BY, Boyeson MG, et al. The effect of seizures on recovery of function following cortical contusion in the rat. Brain Inj 1987;1:27-32.
24. Schmanke T, Barth TM. Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. J Neurotrauma 1997;14:459-68.
25. Schmanke TD, Avery RA, Barth TM. The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task. J Neurotrauma 1996;13:293-307.
26. Strome EM, Cepeda IL, Sossi V, et al. Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal PET compared to behavioral assessment and autoradiography. Mol Imaging Biol 2006;8:292-9.
27. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 3rd ed. San Diego: Academic Press; 1997.
28. Schallert T, Fleming SM, Leasure JL, et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000;39:777-87.
29. Schallert T, Woodlee MT. Orienting and placing. In: Whishaw IQ, Kolb B, editors. The behavior of the laboratory rat: a handbook with tests. Oxford: Oxford University Press; 2005. p. 129-140.
30. Zhao CS, Puurunen K, Schallert T, et al. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 2005;158:211-20.
31. Zar JH. Biostatistical analysis. 4th ed. Upper Saddle River (NJ): Prentice-Hall; 1999.
32. Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther 1996;12:217-23.
33. Zetterstrom TSC, Pei Q, Grahame-Smith DG. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 1998;57:106-10.
34. 11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter. Nucl Med Biol 1994;21:151-6.
35. Liberatore GT, Wong JYF, Krenus D, et al. Tissue fixation prevents contamination of tritium-sensitive storage phosphor imaging plates. Biotechniques 1999;26:432-4.
36. 2 receptors. J Neurosci Methods 2005;141:143-54.
37. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A 1992;89:8155-9.
38. Wielosz M. Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Neuropharmacology 1981;20:941-5.
39. 2-like dopamine receptors. Psychopharmacology (Berl) 1997;133:77-84.
40. Green AR, Heal DJ, Grahame-Smith DG. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional ability of brain 5-hydroxytryptamine and dopamine. Psychopharmacology (Berl) 1977;52:195-200.
41. Dunnett SB, Whishaw IQ, Rogers DC, et al. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res 1987;415:63-78.
42. Evenden JL, Robbins TW. Effects of unilateral 6-hydroxydopamine lesions of the caudate-putamen on skilled forepaw use in the rat. Behav Brain Res 1984;14:61-8.
43. Shi L-H, Woodward DJ, Luo F, et al. High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. Brain Res 2004;1013:98-106.
44. Dowd E, Monville C, Torres EM, et al. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur J Neurosci 2005;22:2587-95.
45. Tillerson JL, Cohen AD, Philhower J, et al. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 2001;21:4427-35.
46. Cohen AD, Tillerson JL, Smith AD, et al. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Ncurochem 2003;85:299-305.
47. Cepeda IL, Flores J, Cornfeldt ML, et al. Intrastriatal implantation of microcarrier attached human retinal pigment epithelial cells ameliorates motor deficits in a rat model of Parkinson's disease (PD). Soc Neurosci Abstr 2004;790-18.
48. Hwang DY, Fleming SM, Ardayfio P, et al. 3,4-dihydroxypheny-lalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci 2005;25:2132-7.
49. 2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 1995;9:41-53.
50. 1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res 1990;514:93-102.
51. 2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism. Synapse 2000;38:105-13.
52. 11C]N-methylspiperone. J Nucl Med 2000;41:65-70.
53. 3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther 2000;295:1223-31.
54. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci U S A 1995;92:1719-23.
55. 3 receptor mRNA in a rodent model of behavioural sensitization to levodopa. Neuroscience 2003;116:307-14.
56. Fochtmann LJ, Cruciani R, Aiso M, et al. Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra. Eur J Pharmacol 1989;167:305-6.
57. Nowak G, Zak J. Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats. Eur J Pharmacol 1989;167:307-8.
58. Barkai AI, Durkin M, Nelson HD. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study. Brain Res 1990;529:208-13.
59. Bergstrom DA, Kellar KJ. Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature 1979;278:464-6.
60. Reches A, Wagner HR, Barkai AI, et al. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. Psychopharmacology (Berl) 1984;83:155-8.
61. 2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments. Pharmacol Biochem Behav 1995;51:565-9.
62. 3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 2000;5:378-88.
63. Araki T, Tanji H, Kato H, et al. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurol Sci 1998;160:121-7.
64. 3 receptor in the rat brain. Neuroscience 1995;65:731-45.
65. 3 receptor expression as a mechanism of behavioral sensitization to levodopa, Proc Natl Acad Sci U S A 1997;94:3363-7.
66. 3 receptor expression and triggers behavioural sensitization. Nature 2001;411:86-9.
67. Altar CA, Whitehead RE, Chen R, et al. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003;54:703-9.
68. Jacobsen JP, Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004;1024:183-92.
69. Bordet R, Ridray S, Schwartz JC, et al. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine- lesioned rats. Eur J Neurosci 2000;12:2117-23.
70. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 1998;10:1676-86.